The nociceptin orphanin FQ peptide receptor agonist, Ro64-6198, impairs recognition memory formation through interaction with glutamatergic but not cholinergic receptor antagonists

Neurobiology of Learning and Memory

Volumn 98, Issue 3, 2012, Pages 254-260

  Reiss, David ^a   Prinssen, Eric P ^b   Wichmann, Jürgen ^b   Kieffer, Brigitte L ^a,c   Ouagazzal, Abdel Mouttalib ^a,d  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b PRED Hoffmann La Roche   (Switzerland)

^c INSERM   (France)

^d CNRS   (France)

Author keywords

Acetylcholine; Glutamate; Learning and memory; Mice; NOP receptor

Indexed keywords

8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; DIZOCILPINE; GLUTAMIC ACID; MECAMYLAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NOCICEPTIN RECEPTOR; SCOPOLAMINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; LONG TERM MEMORY; MALE; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECOGNITION; TASK PERFORMANCE; VISUAL DISCRIMINATION; VISUAL MEMORY;

ANIMALS; CHOLINERGIC ANTAGONISTS; DIZOCILPINE MALEATE; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; IMIDAZOLES; MALE; MECAMYLAMINE; MICE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID; RECOGNITION (PSYCHOLOGY); SCOPOLAMINE HYDROBROMIDE; SPIRO COMPOUNDS;

EID: 84868325312     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2012.09.002     Document Type: Article

References (53)

1. Balderas I., Morin J.P., Rodriguez-Ortiz C.J., Bermudez-Rattoni F. Muscarinic receptors activity in the perirhinal cortex and hippocampus has differential involvement in the formation of recognition memory. Neurobiology of Learning and Memory 2012, 97:418-424.
2. Bongsebandhu-phubhakdi S., Manabe T. The neuropeptide nociceptin is a synaptically released endogenous inhibitor of hippocampal long-term potentiation. Journal of Neuroscience 2007, 27:4850-4858.
3. Calo G., Guerrini R., Rizzi A., Salvadori S., Regoli D. Pharmacology of nociceptin and its receptor: A novel therapeutic target. British Journal of Pharmacology 2000, 129:1261-1283.
4. Cavallini S., Marino S., Beani L., Bianchi C., Siniscalchi A. Nociceptin inhibition of acetylcholine efflux from different brain areas. NeuroReport 2003, 14:2167-2170.
5. Ces A., Reiss D., Walter O., Wichmann J., Prinssen E.P., Kieffer B.L., et al. Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: Comparison to dopamine receptor agonists. Neuropsychopharmacology 2012, 37:378-389.
6. Chiou L.C., Liao Y.Y., Fan P.C., Kuo P.H., Wang C.H., Riemer C., et al. Nociceptin/orphanin FQ peptide receptors: Pharmacology and clinical implications. Current Drug Targets 2007, 8:117-135.
7. Darland T., Heinricher M.M., Grandy D.K. Orphanin FQ/nociceptin: A role in pain and analgesia, but so much more. Trends in Neurosciences 1998, 21:215-221.
8. Digby G.J., Shirey J.K., Conn P.J. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders. Molecular BioSystems 2010, 6:1345-1354.
9. Dodart J.C., Mathis C., Ungerer A. Scopolamine-induced deficits in a two-trial object recognition task in mice. NeuroReport 1997, 8:1173-1178.
10. Eichenbaum H., Yonelinas A.P., Ranganath C. The medial temporal lobe and recognition memory. Annual Review of Neuroscience 2007, 30:123-152.
11. Ellis J.R., Ellis K.A., Bartholomeusz C.F., Harrison B.J., Wesnes K.A., Erskine F.F., et al. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. International Journal of Neuropsychopharmacology 2006, 9:175-189.
12. Feiro O., Gould T.J. The interactive effects of nicotinic and muscarinic cholinergic receptor inhibition on fear conditioning in young and aged C57BL/6 mice. Pharmacology, Biochemistry and Behavior 2005, 80:251-262.
13. Fernandez de Sevilla D., Nunez A., Borde M., Malinow R., Buno W. Cholinergic-mediated IP3-receptor activation induces long-lasting synaptic enhancement in CA1 pyramidal neurons. Journal of Neuroscience 2008, 28:1469-1478.
14. Fornari R.V., Soares J.C., Ferreira T.L., Moreira K.M., Oliveira M.G. Effects of nociceptin/orphanin FQ in the acquisition of contextual and tone fear conditioning in rats. Behavioral Neuroscience 2008, 122:98-106.
15. Furey M.L. The prominent role of stimulus processing: Cholinergic function and dysfunction in cognition. Current Opinion in Neurology 2011, 24:364-370.
16. Giovannini M.G. The role of the extracellular signal-regulated kinase pathway in memory encoding. Reviews in the Neurosciences 2006, 17:619-634.
17. Goeldner C., Reiss D., Wichmann J., Kieffer B.L., Ouagazzal A.M. Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms. Neurobiology of Learning and Memory 2009, 91:393-401.
18. Goeldner C., Reiss D., Wichmann J., Meziane H., Kieffer B.L., Ouagazzal A.M. Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus. Journal of Neuroscience 2008, 28:2190-2198.
19. Green A., Ellis K.A., Ellis J., Bartholomeusz C.F., Ilic S., Croft R.J., et al. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans. Pharmacology, Biochemistry and Behavior 2005, 81:575-584.
20. Hawes B.E., Graziano M.P., Lambert D.G. Cellular actions of nociceptin: Transduction mechanisms. Peptides 2000, 21:961-967.
21. Herrera-Morales W., Mar I., Serrano B., Bermudez-Rattoni F. Activation of hippocampal postsynaptic muscarinic receptors is involved in long-term spatial memory formation. European Journal of Neuroscience 2007, 25:1581-1588.
22. Higgins G.A., Kew J.N., Richards J.G., Takeshima H., Jenck F., Adam G., et al. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. European Journal of Neuroscience 2002, 15:911-922.
23. Hiramatsu M., Inoue K. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice. British Journal of Pharmacology 1999, 127:655-660.
24. Houtani T., Nishi M., Takeshima H., Sato K., Sakuma S., Kakimoto S., et al. Distribution of nociceptin/orphanin FQ precursor protein and receptor in brain and spinal cord: A study using in situ hybridization and X-gal histochemistry in receptor-deficient mice. The Journal of Comparative Neurology 2000, 424:489-508.
25. Itoh K., Konya H., Takai E., Masuda H., Nagai K. Modification of acetylcholine release by nociceptin in conscious rat striatum. Brain Research 1999, 845:242-245.
26. Jenck F., Ouagazzal A.M., Pauly-Evers M., Moreau J.L. Orphanin FQ: Role in behavioral fear responses and vulnerability to stress?. Molecular Psychiatry 2000, 5:572-574.
27. Jones C.K., Byun N., Bubser M. Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia. Neuropsychopharmacology 2012, 37:16-42.
28. Kuzmin A., Madjid N., Johansson B., Terenius L., Ogren S.O. The nociceptin system and hippocampal cognition in mice: A pharmacological and genetic analysis. Brain Research 2009, 1305(Suppl.):S7-19.
29. Lambert D.G. The nociceptin/orphanin FQ receptor: A target with broad therapeutic potential. Nature Reviews Drug Discovery 2008, 7:694-710.
30. Ludbrook J. Statistics in biomedical laboratory and clinical science: Applications, issues and pitfalls. Medical Principles and Practice 2008, 17:1-13.
31. Mamiya T., Yamada K., Miyamoto Y., Konig N., Watanabe Y., Noda Y., et al. Neuronal mechanism of nociceptin-induced modulation of learning and memory: Involvement of N-methyl-D-aspartate receptors. Molecular Psychiatry 2003, 8:752-765.
32. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 1998, 394:577-581.
33. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995, 377:532-535.
34. Micheau J., Marighetto A. Acetylcholine and memory: A long, complex and chaotic but still living relationship. Behavioural Brain Research 2011, 221:424-429.
35. Miranda M.I., Ferreira G., Ramirez-Lugo L., Bermudez-Rattoni F. Role of cholinergic system on the construction of memories: Taste memory encoding. Neurobiology of Learning and Memory 2003, 80:211-222.
36. Mollereau C., Mouledous L. Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 2000, 21:907-917.
37. Neal C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., et al. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. The Journal of Comparative Neurology 1999, 412:563-605.
38. New D.C., Wong Y.H. The ORL1 receptor: Molecular pharmacology and signalling mechanisms. Neurosignals 2002, 11:197-212.
39. Pepeu G., Giovannini M.G. Cholinesterase inhibitors and memory. Chemico-Biological Interactions 2010, 187:403-408.
40. Redrobe J.P., Calo G., Guerrini R., Regoli D., Quirion R. [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats. British Journal of Pharmacology 2000, 131:1379-1384.
41. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 270:792-794.
42. Riekkinen P., Sirvio J., Aaltonen M., Riekkinen P. Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning. Pharmacology, Biochemistry and Behavior 1990, 37:405-410.
43. Robinson L., Platt B., Riedel G. Involvement of the cholinergic system in conditioning and perceptual memory. Behavioural Brain Research 2011, 221:443-465.
44. Roozendaal B., Lengvilas R., McGaugh J.L., Civelli O., Reinscheid R.K. Orphanin FQ/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation. Learning and Memory 2007, 14:29-35.
45. Sandin J., Ogren S.O., Terenius L. Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat. Brain Research 2004, 997:222-233.
46. Sarter M., Bruno J.P., Givens B. Attentional functions of cortical cholinergic inputs: What does it mean for learning and memory?. Neurobiology of Learning and Memory 2003, 80:245-256.
47. Slinker B.K. The statistics of synergism. Journal of Molecular and Cellular Cardiology 1998, 30:723-731.
48. Steckler T., Drinkenburg W.H., Sahgal A., Aggleton J.P. Recognition memory in rats - I. Concepts and classification. Progress in Neurobiology 1998, 54:289-311.
49. Steckler T., Drinkenburg W.H., Sahgal A., Aggleton J.P. Recognition memory in rats - II. Neuroanatomical substrates. Progress in Neurobiology 1998, 54:313-332.
50. Uezu K., Sano A., Sei H., Toida K., Houtani T., Sugimoto T., et al. Enhanced hippocampal acetylcholine release in nociceptin-receptor knockout mice. Brain Research 2005, 1050:118-123.
51. Wei W.Z., Xie C.W. Orphanin FQ suppresses NMDA receptor-dependent long-term depression and depotentiation in hippocampal dentate gyrus. Learning and Memory 1999, 6:467-477.
52. Winters B.D., Saksida L.M., Bussey T.J. Object recognition memory: Neurobiological mechanisms of encoding, consolidation and retrieval. Neuroscience and Biobehavioral Reviews 2008, 32:1055-1070.
53. Yu T.P., Xie C.W. Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms. Journal of Neurophysiology 1998, 80:1277-1284.